KFSHRC Showcases Healthcare Innovations at Arab Health 2025

King Faisal Specialist Hospital and Research Centre (KFSHRC) will participate in Arab Health 2025, held in Dubai from January 27 to 30, showcasing its leading healthcare innovations and specialized Centers of Excellence, according to the Saudi Press Agency. This participation highlights the institution’s commitment to advancing medical technology and strengthening Saudi Arabia’s role in global healthcare.

Context and Background

Arab Health 2025, one of the largest healthcare exhibitions in the region, is expected to host more than 60,000 visitors, providing a platform for global stakeholders to explore emerging trends and envision the future of healthcare. KFSHRC’s booth will spotlight its achievements in oncology, organ transplantation, cardiology, and genomics—fields where the institution has established itself as a leader regionally and globally over decades. Notably, KFSHRC achieved the world’s first fully robotic heart transplant and has pioneered the local production of T-cells, reducing costs associated with international manufacturing and enhancing the Kingdom’s specialized healthcare capabilities.

Key Details and Leadership Insights

KFSHRC’s Deputy Chief Executive Officer Dr. Björn Zoëga will join a panel discussion titled “Investing in KSA’s Healthcare Future: Achieving Vision 2030,” sharing insights into the hospital’s innovations in specialized healthcare and their impact on advancing medical tourism in Saudi Arabia. KFSHRC serves patients from 17 countries, including 77% from the GCC, positioning itself as the premier choice for those seeking accurate diagnoses and cutting-edge treatments. The institution aims to attract 5% of patients seeking treatment abroad, supporting its vision of becoming a global destination for specialized healthcare.

International Impact

KFSHRC’s participation at Arab Health 2025 underscores the Kingdom’s growing influence in global healthcare. The institution has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 academic medical centers for the second consecutive year. It has also been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings, and was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. These accolades reflect KFSHRC’s dedication to innovation and patient care on a global scale.

Vision 2030 Alignment

KFSHRC’s showcase at Arab Health 2025 directly aligns with Saudi Arabia’s Vision 2030, particularly the goal of diversifying the economy and establishing the Kingdom as a hub for advanced healthcare and medical tourism. By driving innovation, reducing reliance on overseas medical care, and attracting international patients, KFSHRC contributes to the broader ambition of building a vibrant society and a thriving economy. This participation reinforces the institution’s role in supporting the Kingdom’s long-term vision of achieving global leadership in specialized healthcare.

20 Questions

Q1. What is Arab Health 2025?

A1. Arab Health 2025 is a major healthcare exhibition and conference held in Dubai from January 27 to 30, bringing together global healthcare professionals, innovators, and policymakers to explore emerging trends and advancements.

Q2. Where is KFSHRC based?

A2. KFSHRC is based in Riyadh, Saudi Arabia, and is a leading academic medical center specializing in oncology, organ transplantation, cardiology, and genomics.

Q3. What is KFSHRC showcasing at Arab Health 2025?

A3. KFSHRC is showcasing its healthcare innovations, including achievements in fully robotic heart transplants and local T-cell production, as well as its Centers of Excellence in specialized medical fields.

Q4. How many visitors is Arab Health 2025 expected to host?

A4. Arab Health 2025 is expected to host more than 60,000 visitors, making it a significant platform for global healthcare collaboration.

Q5. Who is Dr. Björn Zoëga?

A5. Dr. Björn Zoëga is the Deputy Chief Executive Officer of KFSHRC, who will participate in a panel discussion at Arab Health 2025 on healthcare investments in Saudi Arabia.

Q6. What panel discussion will Dr. Björn Zoëga join?

A6. Dr. Björn Zoëga will join a panel titled “Investing in KSA’s Healthcare Future: Achieving Vision 2030,” discussing innovations and medical tourism in Saudi Arabia.

Q7. What is the world’s first fully robotic heart transplant?

A7. The world’s first fully robotic heart transplant was a landmark surgery performed by KFSHRC, showcasing its leadership in advanced surgical techniques and innovation.

Q8. How does local T-cell production benefit Saudi Arabia?

A8. Local T-cell production reduces costs associated with international manufacturing and enhances the Kingdom’s specialized healthcare capabilities for treating cancer and other diseases.

Q9. From how many countries does KFSHRC serve patients?

A9. KFSHRC serves patients from 17 countries, with 77% from the GCC, highlighting its regional and international reach.

Q10. What is KFSHRC’s goal for attracting patients from abroad?

A10. KFSHRC aims to attract 5% of patients seeking treatment abroad, positioning itself as a global destination for specialized healthcare.

Q11. How is KFSHRC ranked globally among academic medical centers?

A11. KFSHRC is ranked first in the Middle East and Africa and 20th globally among the world’s top 250 academic medical centers for the second consecutive year.

Q12. What recognition did KFSHRC receive from Brand Finance in 2024?

A12. KFSHRC was recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings.

Q13. Was KFSHRC included in Newsweek’s World’s Best Smart Hospitals list?

A13. Yes, KFSHRC was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine, recognizing its technological advancements.

Q14. What is Vision 2030 in relation to healthcare?

A14. Vision 2030 is Saudi Arabia’s strategic framework to diversify the economy and develop public services, including establishing the Kingdom as a hub for advanced healthcare and medical tourism.

Q15. How does KFSHRC support medical tourism in Saudi Arabia?

A15. KFSHRC supports medical tourism by offering cutting-edge treatments and technologies, attracting international patients and boosting the Kingdom’s healthcare sector.

Q16. What are the Centers of Excellence at KFSHRC?

A16. The Centers of Excellence at KFSHRC specialize in oncology, organ transplantation, cardiology, and genomics, offering world-class care and research.

Q17. Why is KFSHRC’s participation in Arab Health 2025 important?

A17. It reinforces KFSHRC’s commitment to exploring healthcare trends and showcasing innovations that enhance its global leadership and support Saudi Arabia’s Vision 2030.

Q18. How does KFSHRC contribute to Saudi Arabia’s economy?

A18. By attracting international patients and reducing reliance on overseas medical care, KFSHRC supports economic diversification under Vision 2030.

Q19. What percentage of KFSHRC’s patients are from the GCC?

A19. 77% of KFSHRC’s patients are from the GCC, reflecting its strong regional presence and appeal to neighboring countries.

Q20. What is KFSHRC’s long-term vision?

A20. KFSHRC aims to establish itself as a global destination for specialized healthcare, driving innovation and improving patient outcomes worldwide.

---